Print Page   |   Sign In   |   Join!
DVSHP Student Poster Presentation Night 2019
Register View Registrations Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 11/19/2019
When: 11/19/2019
6:00 PM
Where: Temple University School of Pharmacy, Student Faculty Center – 4th floor
3340 North Broad Street
Philadelphia, Pennsylvania  19140
United States
Contact: Andy Hui


Online registration is available until: 11/15/2019
« Go to Upcoming Event List  

The Delaware Valley Society of Health-System Pharmacists

Established 1938

is proud to invite you to:

Delaware Valley Society of Health-System Pharmacists Student Poster Presentation Night

Overview:

You are cordially invited to join the Delaware Valley Society of Health-System Pharmacists for our Student Poster Presentation Night.

Featured posters will include topics surrounding new, improved or innovative roles or services in pharmacy practice, evaluation of pharmacy-driven protocols/initiatives, or unusual clinical cases in one or a few patients that have not been formally evaluated in the literature.

Free CE provided for licensed pharmacists and technicians who attend the poster session. Light refreshments will be served.

When:


Tuesday, November 19, 2019
5:30 PM – 8:00 PM

 

RSVP Deadline:

 

Friday, November 15, 2019

 

Agenda:

5:30 PM – 6:00 PM: Registration / Board Meeting (Open to all members)

6:00 PM – 6:45 PM: “Defining Our Profession 2020 and Beyond: Entrustable Professional Activities” presented by Dr. Calligaro and Dr. Theodorou

6:45 PM – 7:45 PM: Student Poster Presentations

7:45 PM – 8:00 PM: Awards Ceremony

 

Location:

Temple University School of Pharmacy, Student Faculty Center – 4th floor (see map below)

3340 North Broad Street

Philadelphia, PA 19140

 

Parking:

Ontario East Garage

1225-1299 West Ontario St.

Philadelphia, PA 19140 

[Note: Entrance on Ontario St. between Broad St. and Germantown Ave. Garage is adjacent to Temple University Hospital (from Broad St. proceed 400 feet to the parking garage entrance on the left); parking vouchers will be provided at event check-in the night of.]

 

 

Featured Lecture:

Title:Defining Our Profession 2020 and Beyond: Entrustable Professional Activities”

 

Presenters:

Ina Lee Calligaro, PharmD

Senior Associate Dean for Professional Programs

Associate Professor of Clinical Pharmacy

Temple University School of Pharmacy

Department of Pharmacy Practice

 

Jacqueline Theodorou, PharmD, BCPS

Adjunct Clinical Assistant Professor

Temple University School of Pharmacy

Department of Pharmacy Practice

 

Poster Presentations:

Learning Objectives:

  1. Discuss innovative roles or services in pharmacy practice in addition to findings from evaluations of pharmacy-driven protocols/initiatives.

  2. Review unique clinical patient cases and adverse events that may not be formally evaluated in the literature.

     

Titles:

  • HIV/HCV Point of Care Testing in Outpatient Pharmacies

  • Dextromethorphan abuse resulting in acetaminophen toxicity using a non-prescription cough/cold product

  • Levamisole induced agranulocytosis

  • Nitrofurantoin-induced Pulmonary Toxicity

  • Utilizing pharmacy students to impact readmission rates involving high-risk adult patient populations in an acute care inpatient setting

  • Evaluation of Appropriate Loading Doses of Amiodarone

  • Enzalutamide-induced seizure

  • Use of ascorbic acid, thiamine, and hydrocortisone for sepsis in a tertiary medical center

  • Combination of Chemotherapy Drug and Etoposide against Triple Negative Breast Cancer Growth and Invasion

  • Role of a Clinical Pharmacist in Stroke Risk Factor Reduction

  • Exploring the Prevalence and Characteristics Associated with Weight Gain and Metabolic Changes in Patients Living with HIV Infection who are Virologically Suppressed on Antiretroviral Therapy and Switch to Integrase Inhibitor Containing Regimens

  • Assessing the utilization of procalcitonin levels in a community hospital as part of an antimicrobial stewardship program

  • Awareness of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) point of care (POC) testing amongst community pharmacists.

  • Evaluation of bivalirudin anticoagulation in patients undergoing extracorporeal membrane oxygenation

  • Prescribing Patterns in the Treatment of New Onset Diabetes after Transplantation (NODAT) in Kidney Transplant Recipients

  • Factors Associated with the Clearance of High-Dose Methotrexate in Pediatric Hematology/Oncology Patients

  • Role of a Clinical Pharmacist in Secondary Stroke Prevention and Patient Specific Factors Affecting Time to Recurrent Stroke.

  • Impact of obesity on glycemic control in adult hospitalized patients initiated on parenteral nutrition

  • Prescribing patterns associated with the transition from low molecular weight heparin to direct oral anticoagulation in patients with cancer-associated thrombosis

  • Comparison of LACE-rt and MEDCOINS in identifying patients for pharmacy student-led transitions of care services

  • Sertraline induced syndrome of inappropriate antidiuretic hormone

  • Exploring second professional year pharmacy student reflections after an interprofessional shadowing experience with nursing students in critical care units: a qualitative study

  • S100A4 promotes Breast Cancer Metastasis

  • Method of Fibrosis Assessment and Impact on Hepatitis C Treatment

  • Impact of student pharmacist medication histories on the neurology service unit

  • Retrospective Evaluation of Tight Glycemic Control utilizing the Portland Protocol in Cardiac Surgery ICU patients

  • Drug-drug interactions between concomitant antineoplastic and antiretroviral therapies

  • An Evaluation of the Appropriate Use of Oral Metronidazole at Temple University Hospital

  • Utilizing advanced pharmacy practice experience students to increase nephropathy quality metric

  • Outcomes in kidney transplant recipients with acute rejection within the first 12 months post-transplant

  • Evaluation of appropriate use of clindamycin to treat skin and soft tissue infections prior to implementation of new guidelines and provider education.

  • Assessing Antibiotic Change from the Emergency Department Upon Transition of Care to Inpatient Admission

  • Evaluating the impact of a targeted naloxone protocol on naloxone dispensing for high risk patients in a community pharmacy setting

     

CE Information:

 

Acknowledgement of Financial Commercial Support 

No financial commercial support was received for this educational activity.

Satisfactory Completion 

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Pennsylvania Society of Health-System Pharmacists - DVSHP.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.75 knowledge-based contact hours for pharmacists/pharmacist technicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.  UAN: JA4008163-9999-19-125-L04-P(K), JA4008163-9999-19-125-L04-T(K).

NOTE: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Objectives - After attending this program you should be able to:
1. Discuss innovative roles or services in pharmacy practice in addition to findings from evaluations of pharmacy-driven protocols/initiatives.
2. Review unique clinical patient cases and adverse events that may not be formally evaluated in the literature.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.
No presenter Disclosed a financial relationship with a commercial interest.

 

 

 

 


Membership Management Software Powered by YourMembership  ::  Legal